# Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients

> **NCT04654689** · PHASE2 · COMPLETED · sponsor: **Fundación Universidad Católica de Valencia San Vicente Mártir** · enrollment: 90 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** Liposomed polyphenols resveratrol and curcumin
- **OTHER:** Placebo for liposomed resveratrol and curcumin
- **DIETARY_SUPPLEMENT:** Isocaloric Diet
- **DRUG:** G04CB02
- **OTHER:** Placebo microcrystalline methylcellulose

## Key facts

- **NCT ID:** NCT04654689
- **Lead sponsor:** Fundación Universidad Católica de Valencia San Vicente Mártir
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-20
- **Primary completion:** 2022-11-12
- **Final completion:** 2023-02-04
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654689, "Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04654689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*